Sector-Specific AI Regulation Updated 2026-03-15 Sector-specific AI regulation covering FDA oversight of AI in medical devices, SEC model risk guidance, OCC banking AI requirements, and FTC enforcement against deceptive AI practices.
What You'll Learn
Understand how sector-specific regulators approach AI oversight in their domains
Identify FDA requirements for AI/ML-enabled medical devices (SaMD)
Navigate SEC and OCC guidance on AI model risk in financial services
Recognize FTC enforcement patterns for deceptive AI practices
Map sector-specific requirements to red team testing methodologies
While horizontal AI frameworks like the EU AI Act and NIST AI RMF apply broadly, some of the most consequential AI regulation comes from sector-specific regulators who have adapted existing authority to address AI risks within their domains. Red teamers working in regulated industries must understand these sector-specific requirements because they create binding obligations that go beyond voluntary frameworks and carry significant enforcement penalties.
The Food and Drug Administration regulates AI and machine learning through its authority over Software as a Medical Device (SaMD)
Pathway Risk Level AI Examples Timeline 510(k) (Substantial equivalence)Low-moderate AI-assisted image analysis, clinical decision support 3-6 months De Novo (Novel low-moderate risk)Low-moderate, novel New AI diagnostic categories without predicate devices 6-12 months PMA (Premarket approval)High risk AI systems making autonomous clinical decisions 12-24 months Breakthrough Device Variable, urgent need AI diagnostics for conditions with no alternatives Expedited review
Requirement Description Red Team Testing Approach Good Machine Learning Practice (GMLP) Fundamental principles for AI/ML device development Verify adherence to documented development practices Predetermined Change Control Plan Documentation of anticipated model updates and validation criteria Test whether model updates follow the documented plan Real-World Performance monitoring Continuous monitoring of AI device performance in clinical settings Assess monitoring effectiveness, test for performance degradation detection Algorithm transparency Clear documentation of algorithm function, training data, and limitations Verify documentation accuracy against actual system behavior Bias and robustness testing Testing across diverse patient populations and clinical conditions Adversarial robustness testing, demographic bias assessment
Test Category Methodology Clinical Relevance Adversarial perturbation Apply adversarial perturbations to medical images to test diagnostic accuracy Could cause missed diagnoses or false positives Distribution shift Test model performance with out-of-distribution data (different demographics, equipment, facilities) Real-world deployment exposes models to diverse patient populations Data poisoning Assess vulnerability of continuous learning systems to training data manipulation Could systematically degrade diagnostic accuracy Boundary conditions Test with edge-case clinical presentations that fall between diagnostic categories Where clinical AI most often fails Temporal drift Assess model performance against evolving disease presentations and treatment protocols Medical knowledge evolves; models must keep pace
Document Focus Red Team Relevance Artificial Intelligence and Machine Learning in Software as a Medical Device (2021) Overall regulatory framework Foundational requirements Clinical Decision Support Software Guidance (2022) CDS-specific requirements Scope determination for clinical AI Marketing Submission Recommendations for a Predetermined Change Control Plan (2023) Model update governance Testing requirements for model changes Diversity Considerations in Clinical Studies (2024) Demographic representation Bias testing requirements
The Securities and Exchange Commission addresses AI primarily through its existing authority over market integrity, investor protection, and regulated entity governance.
Focus Area Regulatory Basis Requirements Predictive analytics in investor interactions Regulation Best Interest, Investment Advisers Act Must not use AI to place firm interests above client interests AI in trading Market manipulation rules, Regulation SCI AI trading systems must not create market instability AI in disclosure Disclosure requirements, anti-fraud provisions AI-related risks must be disclosed to investors AI washing Anti-fraud provisions Must not misrepresent AI capabilities to investors Cybersecurity Reg S-P, Reg SCI AI systems must meet cybersecurity requirements
The SEC has taken enforcement action against AI-related misrepresentation and signaled increasing scrutiny:
Action/Guidance Date Key Takeaway AI washing enforcement (DWS, Global Predictions) 2024 SEC penalizes companies for misrepresenting AI capabilities Proposed rules on predictive analytics 2023-ongoing May require elimination of conflicts of interest in AI-driven advice Reg SCI amendments discussion 2024-ongoing Expanding cybersecurity requirements to cover AI systems Staff guidance on AI in investment advice 2024 Investment advisers must supervise AI-driven recommendations
Test Category Methodology Regulatory Concern Conflict of interest detection Test whether AI recommendations favor the firm over clients Reg BI, fiduciary duty violations Market manipulation potential Assess whether AI trading systems can be manipulated to create market instability Market manipulation rules AI capability verification Verify that AI capabilities match marketing claims Anti-fraud, AI washing concerns Data security Test data protection for AI systems handling investor data Reg S-P requirements Model validation Independent validation of AI model performance claims SR 11-7 model risk management
The Office of the Comptroller of the Currency, along with the Federal Reserve and FDIC, has established expectations for AI use in banking through existing model risk management guidance and new AI-specific supervisory approaches.
The foundational guidance for AI oversight in banking is SR 11-7
SR 11-7 Component Traditional Application AI/ML Extension Model development Documented methodology, theoretical basis Explainability requirements, training data documentation Model validation Independent testing, backtesting Adversarial testing, bias assessment, robustness evaluation Model governance Model inventory, approval process AI model lifecycle management, version control Ongoing monitoring Performance tracking, threshold alerts Drift detection, adversarial monitoring, fairness metrics
Regulation/Guidance Scope Key AI Requirements Fair lending laws (ECOA, FHA)Lending decisions AI lending models must not discriminate against protected classes BSA/AML Anti-money laundering AI transaction monitoring must be effective and explainable CRA (Community Reinvestment Act)Community lending AI must not create digital redlining or exclude underserved communities FCRA (Fair Credit Reporting Act)Credit decisions Adverse action notices must explain AI-driven credit decisions Interagency fair lending guidance (2023-ongoing)All lending AI Specific expectations for testing AI lending models for discrimination
Test Area Methodology Regulatory Requirement Disparate impact analysis Test lending model outcomes across protected classes (race, gender, age, national origin) ECOA, FHA compliance Model extraction Attempt to extract proprietary model logic through API queries Model security, competitive protection Adversarial evasion Test whether AML monitoring can be evaded through adversarial transactions BSA/AML effectiveness Explainability testing Assess whether AI decisions can be adequately explained to consumers FCRA adverse action requirements Input manipulation Test whether applicant-side data manipulation can bias outcomes Model robustness, fraud detection
The Federal Trade Commission uses its authority under Section 5 of the FTC Act (prohibiting unfair or deceptive acts) and other statutes to address AI-related consumer harms.
Focus Area Legal Authority Examples of Enforcement Deceptive AI claims Section 5 (deception) Companies claiming AI capabilities that do not exist Unfair AI practices Section 5 (unfairness) AI that causes substantial consumer harm that is not reasonably avoidable AI and civil rights Section 5, ECOA AI that perpetuates discrimination AI and children COPPA AI systems collecting data from children without parental consent AI and health claims FTC Act, Health Breach Notification Rule AI health products making unsupported claims
Case Year Issue Outcome Rite Aid (facial recognition) 2023 Inaccurate facial recognition wrongly identified customers as shoplifters 5-year ban on facial recognition, required security program DoNotPay ("robot lawyer") 2024 Misrepresented AI as equivalent to a human lawyer $193,000 penalty, prohibited from misleading claims Evolv Technology (weapons detection) 2024 AI weapons detection made inaccurate safety claims Required to stop deceptive marketing, notify customers Amazon (Alexa/Ring and children) 2023 Retained children's voice data beyond necessity $25M penalty, required data deletion
Test Category Methodology FTC Concern Capability verification Independently verify AI performance against marketing claims Deceptive practices if claims are unsupported Consumer harm assessment Identify scenarios where AI outputs could cause financial, physical, or reputational harm Unfair practices if harm is substantial and unavoidable Dark patterns in AI Test whether AI interfaces manipulate consumers into unwanted actions Deceptive design practices Data handling Assess how AI systems collect, retain, and use consumer data Data privacy, COPPA compliance Bias testing Test for discriminatory outcomes across protected classes Civil rights violations
When scoping engagements in regulated industries, identify the applicable sector-specific regulators:
If the Client Is... Primary Regulator(s) Key Testing Focus Healthcare AI company FDA, HHS/OCR Clinical safety, HIPAA, bias across demographics Bank or lender OCC/Fed/FDIC, CFPB Fair lending, model risk management, AML effectiveness Investment firm SEC, FINRA Conflict of interest, AI washing, market stability Consumer-facing AI company FTC Deceptive practices, privacy, consumer harm Insurance company State insurance commissioners, NAIC Actuarial fairness, discrimination, rate-making accuracy Telecommunications FCC Accessibility, robocall/spam detection accuracy
Red team reports for regulated industries should include sector-specific sections:
Section Content Regulatory landscape Which sector-specific regulations apply and why Control mapping Findings mapped to specific regulatory requirements Enforcement risk assessment Likelihood and severity of regulatory action based on findings Remediation with regulatory context Recommendations framed in terms of regulatory compliance Examiner readiness Whether the organization could demonstrate compliance during a regulatory examination
Several trends are shaping the future of sector-specific AI regulation:
Trend Impact Red Team Preparation Interagency coordination Multiple regulators collaborating on AI oversight Expect multi-regulator examination scenarios Mandatory testing Regulators moving from guidance to mandatory testing requirements Build standardized testing capabilities for each sector Real-time monitoring Shift from periodic examination to continuous monitoring Develop automated continuous testing tools Explainability mandates Increasing requirement for AI decision explanations Build explainability assessment into standard methodology Third-party AI risk Regulators scrutinizing use of third-party AI services Include third-party AI assessment in engagement scope
Red teamers who develop deep expertise in sector-specific regulation create significant competitive differentiation. The intersection of technical AI security skills and regulatory domain knowledge is where the most impactful and valued assessments occur.